Hosted on MSN2m
Truist's REITS outlook for 2025, upgrades several stocks
Investing.com -- Truist Securities maintained a neutral outlook on real estate investment trusts for 2025, factoring improving fundamentals but impact of long-term interest rates and tight yield ...
Immunovant CEO Peter Salzmann sells $208,899 in stock
Peter Salzmann, the Chief Executive Officer of Immunovant, Inc. (NASDAQ:IMVT), a $3.49 billion market cap biotech company, ...